newsfilter
← Latest News
GlobeNewswire·

CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized